Ambuja Cement Q4 Review: Pricing In The Benefit, Says IDBI Capital
An Ambuja Cement shop exterior. (Photo: BloombergQuint)

Ambuja Cement Q4 Review: Pricing In The Benefit, Says IDBI Capital

Bookmark

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

IDBI Capital Report

Ambuja Cement Ltd. Q4 CY20 Ebitda was 8% higher than our estimate.

Beat is driven by the volume growth of 7% year on year.

Post the result, we have increased volume growth expectations for ACEM.

This has increased Ebitda estimate by 2%/6% for CY21/22E.

Revenue in Q4 has increased by 12% year on year to Rs 35 billion and is led by volume increase of 8% year on year and realisation increase of 4% year on year.

Absolute Ebitda has increased by 30% year on year to Rs 7.7 billion.

Click on the attachment to read the full report:

IDBI Capital Ambuja Cement Q4 CY20 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.